60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.380
-0.020 (-1.43%)
At close: Oct 30, 2025, 4:00 PM EDT
1.380
0.00 (0.00%)
After-hours: Oct 30, 2025, 4:10 PM EDT
SXTP Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for SXTP stock has a target of 3.00, which predicts a 117.39% increase from the current stock price of 1.38.
Price Target: $3.00 (+117.39%)
Analyst Consensus: Buy
* Price targets were last updated on Sep 3, 2025.
Analyst Ratings
The average analyst rating for SXTP stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7 → $3 | Strong Buy | Maintains | $7 → $3 | +117.39% | Sep 3, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $5.8 → $7 | Strong Buy | Maintains | $5.8 → $7 | +407.25% | Jun 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 10, 2025 |
Financial Forecast
Revenue This Year
1.24M
from 681.35K
Increased by 81.41%
Revenue Next Year
2.26M
from 1.24M
Increased by 83.17%
EPS This Year
-2.19
from -18.55
EPS Next Year
-5.47
from -2.19
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.3M | 2.3M | |
| Avg | 1.2M | 2.3M | |
| Low | 1.2M | 2.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 86.8% | 88.6% | |
| Avg | 81.4% | 83.2% | |
| Low | 74.4% | 76.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.26 | -5.63 | |
| Avg | -2.19 | -5.47 | |
| Low | -2.11 | -5.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.